Rameseder J, Krismer K, Dayma Y, et al. A Multivariate Computational Method to Analyze High-Content RNAi Screening Data. J Biomol Screen. 2015;20(8):985-97. doi:10.1177/1087057115583037
Swamidass J, Bittker JA, Bodycombe NE, Ryder SP, Clemons PA. An economic framework to prioritize confirmatory tests after a high-throughput screen. J Biomol Screen. 2010;15(6):680-6. doi:10.1177/1087057110372803
Swamidass J, Calhoun BT, Bittker JA, Bodycombe NE, Clemons PA. Enhancing the rate of scaffold discovery with diversity-oriented prioritization. Bioinformatics. 2011;27(16):2271-8. doi:10.1093/bioinformatics/btr369
Swamidass J, Calhoun BT, Bittker JA, Bodycombe NE, Clemons PA. Utility-aware screening with clique-oriented prioritization. J Chem Inf Model. 2012;52(1):29-37. doi:10.1021/ci2003285
Green DVS, Clemons PA. Knowledge from Small-Molecule Screening and Profiling Data. J Biomol Screen. 2014;19(5):611-3. doi:10.1177/1087057114531209
Fu S, Yalcin A, Lee GY, et al. Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity. Sci Transl Med. 2015;7(292):292ra98. doi:10.1126/scitranslmed.aaa9134
Ozkumur AY, Goods BA, Love C. Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning. Small. 2015;11(36):4643-50. doi:10.1002/smll.201500674
Hiraki M, Hwang SY, Cao S, et al. Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis. Chem Biol. 2015;22(9):1206-16. doi:10.1016/j.chembiol.2015.07.016
Kennedy AL, Vallurupalli M, Chen L, et al. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget. 2015;6(30):30178-93. doi:10.18632/oncotarget.4903
Logan DJ, Shan J, Bhatia SN, Carpenter AE. Quantifying co-cultured cell phenotypes in high-throughput using pixel-based classification. Methods. 2016;96:6-11. doi:10.1016/j.ymeth.2015.12.002